Aura Biosciences Inc [AURA] stock prices are down -0.74% to $5.36 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AURA shares have gain 7.85% over the last week, with a monthly amount drifted -28.44%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Aura Biosciences Inc [NASDAQ: AURA] stock has seen the most recent analyst activity on July 25, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $21. JMP Securities started tracking the stock assigning a Mkt Outperform rating and suggested a price target of $26 on July 19, 2022.
The stock price of Aura Biosciences Inc [AURA] has been fluctuating between $4.84 and $12.38 over the past year. Currently, Wall Street analysts expect the stock to reach $22.75 within the next 12 months. Aura Biosciences Inc [NASDAQ: AURA] shares were valued at $5.36 at the most recent close of the market. An investor can expect a potential return of 324.44% based on the average AURA price forecast.
Analyzing the AURA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -0.48 and Total Capital is -0.57. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.26 points at the first support level, and at 5.15 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.48, and for the 2nd resistance point, it is at 5.59.
Ratios To Look Out For
It’s worth pointing out that Aura Biosciences Inc [NASDAQ:AURA]’s Current Ratio is 10.77. Also, the Quick Ratio is 10.77, while the Cash Ratio stands at 2.13.
Transactions by insiders
Recent insider trading involved Elazzouzi Amy, Officer, that happened on Apr 16 ’25 when 897.0 shares were purchased. Officer, Kilroy Conor completed a deal on Apr 16 ’25 to buy 7162.0 shares. Meanwhile, Senior Vice President, Finance Elazzouzi Amy sold 897.0 shares on Apr 16 ’25.
